BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
4.070
+0.030 (0.74%)
At close: May 12, 2025, 4:00 PM
4.270
+0.200 (4.91%)
After-hours: May 12, 2025, 5:16 PM EDT
BioAge Labs Market Cap
BioAge Labs has a market cap or net worth of $145.91 million as of May 12, 2025.
Market Cap
145.91M
Enterprise Value
-178.86M
1-Year Change
n/a
Ranking
Category
Stock Price
4.07
Market Cap Chart
Since the IPO on September 26, 2024, BioAge Labs's market cap has decreased from $615.01M to $145.91M, a decrease of -76.28%. That is a compound annual growth rate of -90.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 144.83M | -30.22% |
| Dec 31, 2024 | 207.56M | -66.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |